Products of heme oxygenase and their potential therapeutic applications
Продукты гемоксигеназы и их потенциальное терапевтическое применение
2006-02-03
SCID: 54.1/hfjuxrpe
Discuss with AI
bilirubinbiliverdincarbon monoxideheme oxygenase-1organ transplantation
Figures from the paper
Abstract (AI)
Heme oxygenase 1 (HO-1) is induced in response to cellular stress and is responsible for converting the prooxidant heme molecule into equimolar quantities of biliverdin (BV), carbon monoxide (CO), and iron. BV is then converted to bilirubin (BR) by the enzyme biliverdin reductase. Experimental evidence suggests that induction of the HO system is an important endogenous mechanism for cytoprotection and that the downstream products of heme degradation, CO, BR, and BV, may mediate these powerful beneficial effects. These molecules, which were once considered to be toxic metabolic waste products, have recently been shown to have dose-dependent vasodilatory, antioxidant, and anti-inflammatory properties that are particularly desirable for tissue protection during organ transplantation. In fact, recent work has demonstrated that administration of exogenous CO, BR, or BV may offer a simple, inexpensive method to substitute for the cytoprotective effects of HO-1 in a variety of clinically applicable models. This review will attempt to summarize the relevant biochemical and cytoprotective properties of CO, BR, and BV, and will discuss emerging studies involving the therapeutic applications of these molecules in the kidney and other organ systems.
Key Findings
1
Carbon monoxide, bilirubin, and biliverdin exhibit dose-dependent vasodilatory, antioxidant, and anti-inflammatory properties despite previously being regarded as toxic waste products.
2
Exogenous administration of carbon monoxide, bilirubin, or biliverdin can potentially substitute for HO-1 cytoprotective effects in clinically relevant experimental models.
3
HO-1 protects cells by degrading prooxidant heme into equimolar biliverdin, carbon monoxide, and iron, with biliverdin subsequently converted to bilirubin.
4
The downstream products of heme degradation may mediate HO-1-associated cytoprotection and tissue protection during organ transplantation.
5
These molecules represent potentially simple and inexpensive therapeutic agents for protecting kidneys and other organs, although their applications remain emerging.
Research Object
heme oxygenase system downstream products—carbon monoxide, bilirubin, and biliverdin—in kidney and other organ systems
Research Subject
the dose-dependent vasodilatory, antioxidant, anti-inflammatory, and cytoprotective effects and therapeutic applications of carbon monoxide, bilirubin, and biliverdin
Publication Details
Publication Date
2006-02-03
Journal
Publisher
ISSN
Cited by
226
Access Type
Author Information
Download PDF
Subscribe to digest